In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae
about
Structural Insight into the Antibiotic Action of Telithromycin against Resistant MutantsIn vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrationsPharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh modelMurine models of pneumococcal pneumonia and their applicability to the study of tissue-directed antimicrobials.Species-specific antibiotic-ribosome interactions: implications for drug development.Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis.
P2860
In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
In vivo efficacy of telithromy ...... iae and Haemophilus influenzae
@en
In vivo efficacy of telithromycin
@nl
type
label
In vivo efficacy of telithromy ...... iae and Haemophilus influenzae
@en
In vivo efficacy of telithromycin
@nl
prefLabel
In vivo efficacy of telithromy ...... iae and Haemophilus influenzae
@en
In vivo efficacy of telithromycin
@nl
P2093
P2860
P1476
In vivo efficacy of telithromy ...... iae and Haemophilus influenzae
@en
P2093
P2860
P304
P356
10.1128/AAC.45.11.3250-3252.2001
P407
P577
2001-11-01T00:00:00Z